Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population — Stella

Home/Symptomatic Aortic Stenosis/

View on ClinicalTrials.gov

Recruiting

Back to Symptomatic Aortic Stenosis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

The Second Affiliated Hospital, School of Medicine at Zhejiang University, Hanzhou, Zhejiang

Key details

Phase

Post-approval study

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~2,000 participants

Started

June 2016

Primary completion

July 2026

Age range

18 Years and older

Last updated July 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.